HYPOGLYCEMIA AND KIDNEY EVENTS IN PARTICIPANTS WITH TYPE 2 DIABETES AND ATHEROSCLEROTIC CARDIOVASCULAR DISEASE: OBSERVATIONS FROM THE VERTIS CV TRIAL

WCN23-0356
Chronic Kidney Disease, Hypertension, Diabetes and CVD
Diabetic Kidney Disease, Drugs and Treatments
 
 
 
 
HYPOGLYCEMIA AND KIDNEY EVENTS IN PARTICIPANTS WITH TYPE 2 DIABETES AND ATHEROSCLEROTIC CARDIOVASCULAR DISEASE: OBSERVATIONS FROM THE VERTIS CV TRIAL
Cherney, D.(1)*;Cosentino, F.(2);E. Pratley, R.(3);Dagogo-Jack, S.(4);Mcguire, D.K.(5);Maldonado, M.(6);Frederich, R.(7);Fu, W.(8);
ie: Azwin Z.1, Siti Y.1, John D.2
(1)University Of Toronto, Division Of Nephrology, Toronto, Canada;(2)Karolinska Institute And Karolinska University Hospital Solna, Unit Of Cardiology, Stockholm, Sweden;(3)Adventhealth Translational Research Institute, Diabetes Institute, Orlando, United States;(4)University Of Tennessee Health Science Center, Division Of Endocrinology- Diabetes And Metabolism, Memphis, United States;(5)University Of Texas Southwestern Medical Center- Parkland Health And Hospital System, Division Of Cardiology, Dallas, United States;(6)Msd Uk Limited, Diabetes And Endocrinology, London, United Kingdom;(7)Pfizer Inc., Research And Development, Groton, United States;(8)Merck & Co.- Inc., Biostatistics, Rahway, United States;
https://storage.unitedwebnetwork.com/files/1041/567e4baeeb7928dfbe349488215edfd1.pdf
 
if any